The NF-κB signaling pathway is also involved in regulation of immune checkpoint expression in tumor cells, as NF-κB can induce PD-L1 expression thereby promoting T cell suppression and consequently tumorigenesis [34,35,36,37,38,39,40,41,42,43]. The gene discussed is NFKB1; the disease is neoplasm.